You are here

  • Home
  • Archive
  • Volume 8, Issue 11
  • Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation

Article info

Article menu

Download PDFPDF

Analysis
Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation

Authors

  • Mathew Mercuri Institute on Ethics & Policy for Innovation, McMaster University, Hamilton, Ontario, CanadaMedicine, McMaster University, Hamilton, Ontario, CanadaDala Lana School of Public Health, University of Toronto, Toronto, Ontario, CanadaPhilosophy, McMaster University Faculty of Humanities, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Kristy Hackett Institute on Ethics & Policy for Innovation, McMaster University, Hamilton, Ontario, CanadaDala Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Ross Upshur Dala Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Claudia Isabel Emerson Institute on Ethics & Policy for Innovation, McMaster University, Hamilton, Ontario, CanadaPhilosophy, McMaster University Faculty of Humanities, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mathew Mercuri; mercurmd{at}mcmaster.ca
View Full Text

Citation

Mercuri M, Hackett K, Upshur R, et al
Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation
BMJ Global Health 2023;8:e013480.

Publication history

  • Received July 21, 2023
  • Accepted September 30, 2023
  • First published November 2, 2023.
Online issue publication 
November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.